8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2007 / Randomized controlled trial
Ninety-seven young adolescents were randomized to receive either a daily prebiotic supplement or a maltodextrin control for 1 year. Compared with the control group, subjects receiving prebiotics had a smaller increase in BMI (difference 0.52 +/- 0.16 kg/m2, P = .016), BMI Z-score (difference 0.13 +/- 0.06, P = .048), and total fat mass (difference 0.84 +/- 0.36 kg, P = .022). Among subjects with usual calcium intake >= 700 mg/d, the prebiotic group had a relative change in BMI that was 0.82 kg/m2 less (P < .01) and a BMI Z-score 0.20 less (P = .003) than controls. Differences tended to be maintained 1 year after stopping supplementation.
Abrams SA, Griffin IJ, Hawthorne KM, et al. J Pediatr, 2007. PMID 17719942
2007 / Randomized controlled trial
Untrained overweight adults consumed either a ketogenic or nonketogenic low-carbohydrate hypocaloric diet for two weeks. Weight loss and fat reduction did not differ between arms. At week two, circulating beta-hydroxybutyrate was 3.6 times higher in the ketogenic arm (P = 0.018) and correlated positively with perceived exertion (r2 = 0.22, P = 0.049), perceived fatigue (r = 0.458, P = 0.049), and total mood disturbance during exercise (r = 0.551, P = 0.015).
White AM, Johnston CS, Swan PD, et al. J Am Diet Assoc, 2007. PMID 17904939
2007 / Single-arm intervention study
Seven healthy overweight and obese individuals underwent a 16-week intervention combining a calorie-restricted diet, a lifestyle change program, and 4 g/day of Viscofiber (high-viscosity fermentable fiber from oats and barley). Over 16 weeks, participants lost 3.07 +/- 3.13 kg (P < .05). At 14 weeks compared to baseline, fasting PYY increased by 8.67 +/- 6.62 pg/mL (P < .05), fasting GLP-1 increased by 2.67 +/- 0.84 pmol/L (P < .01), and 1-hour post-meal satiety increased by 1.78 +/- 1.43 cm (P < .01).
Greenway F, O'Neil CE, Stewart L, et al. J Med Food, 2007. PMID 18158848
2006 / Single group uncontrolled trial
Sixteen overweight or obese individuals with chronic spinal cord injury participated in a 12-week weight management program covering nutrition, exercise, and behavior modification, with follow-up through 24 weeks. Participants lost an average of 3.5 +/- 3.1 kg at week 12 and 2.9 +/- 3.7 kg at week 24, alongside significant reductions in BMI, anthropometric measurements, and fat mass, while lean mass, albumin, and hemoglobin were maintained. Improvements were observed in diet behavior and psychosocial and physical functioning. Greater weight loss was correlated (r > 0.4) with greater reductions in total cholesterol at weeks 12 and 24, and in systolic and diastolic blood pressure at week 24.
Chen Y, Henson S, Jackson AB, et al. Spinal Cord, 2006. PMID 16103891
2006 / Two independent controlled studies
Two independent studies evaluated the Tissue Monitoring System (TMS), which provided female college freshmen with daily weight feedback based on linear regression of daily morning weights. Untreated controls gained 3.1+/-0.51 kg in the first study and 2.0+/-0.65 kg in the second study (P<0.01 for both). In contrast, weight gain in the experimental groups was 0.1+/-0.99 kg and -0.82+/-0.56 kg, values that were not significantly different from zero.
Levitsky DA, Garay J, Nausbaum M, et al. Int J Obes (Lond), 2006. PMID 16446748
2006 / Randomized controlled trial
Ninety-one obese patients were randomized to four groups taking treatments three times daily before meals for 12 weeks: placebo capsules plus apple juice, grapefruit capsules plus apple juice, grapefruit juice plus placebo capsules, or half a fresh grapefruit plus placebo capsules. After 12 weeks, weight loss was 1.6 kg with fresh grapefruit, 1.5 kg with grapefruit juice, 1.1 kg with grapefruit capsules, and 0.3 kg with placebo, with fresh grapefruit showing significantly more weight loss than placebo (P < .05). Among patients with metabolic syndrome, weight loss was significantly greater across all three grapefruit groups compared to placebo (P < .02). Fresh grapefruit also significantly reduced 2-hour post-glucose insulin levels compared with placebo.
Fujioka K, Greenway F, Sheard J, et al. J Med Food, 2006. PMID 16579728
2006 / Multicenter, 3-arm, randomized trial
In the PREMIER trial, 810 adults with prehypertension or stage 1 hypertension were randomized to an established behavioral intervention, an established intervention plus the DASH diet, or advice only for 18 months. Compared with advice only, both behavioral interventions significantly reduced weight, fat intake, and sodium intake, while established plus DASH significantly increased intake of fruit, vegetable, dairy, fiber, and minerals. Relative to advice only, the odds ratio for hypertension at 18 months was 0.83 (95% CI, 0.67 to 1.04) for the established group and 0.77 (95% CI, 0.62 to 0.97) for the established plus DASH group. Differences in absolute blood pressure reductions at 18 months between behavioral groups and advice only were not statistically significant.
Elmer PJ, Obarzanek E, Vollmer WM, et al. Ann Intern Med, 2006. PMID 16585662
2006 / Randomized crossover trial
Seven overweight or obese non-diabetic subjects ingested emulsions predominantly containing MUFA, PUFA, SFA, or water control at regular intervals for 24 hours in a random crossover design. Following 24 hours of ingestion, plasma NEFAs increased approximately 1.5- to 2-fold above basal for all fat emulsions, and all three reduced insulin clearance. SFA ingestion reduced insulin sensitivity, and insulin secretion failed to compensate for the insulin resistance. PUFA ingestion was associated with an absolute reduction in glucose-stimulated insulin secretion.
Xiao C, Giacca A, Carpentier A, et al. Diabetologia, 2006. PMID 16596361
2006 / Repeated measures within-subjects crossover study
Thirty-seven participants completed 4 laboratory visits to consume a buffet-style lunch ad libitum under four counterbalanced conditions: eating alone, eating alone watching TV, eating with two strangers, and eating with two friends. Energy intake was significantly higher when eating with familiar others (4565+/-272 kJ, p < 0.001; +18%) and when watching TV (4350+/-252 kJ, p < 0.05; +14%) compared to eating alone (3861+/-200 kJ). A greater percentage of time was focused on food during the alone baseline compared to other conditions (p < 0.001). Eating with strangers drew attention away from food but did not result in increased intake.
Hetherington MM, Anderson AS, Norton GN, et al. Physiol Behav, 2006. PMID 16757007
2006 / Within-subjects experimental crossover trial
In a within-subjects design, 10 undergraduates ate pizza and 10 undergraduates ate macaroni and cheese (M&C) during two 30-minute sessions: one while watching a TV show of their choice and one while listening to a symphony. Television viewing increased caloric intake by 36% (one slice on average) for pizza and by 71% for M&C. For pizza, the time before starting another slice was shorter during television viewing, whereas M&C was eaten at a faster rate and for a longer period of time while watching TV.
Blass EM, Anderson DR, Kirkorian HL, et al. Physiol Behav, 2006. PMID 16822530
2006 / Randomized crossover trial
In a randomized crossover study, healthy young volunteers drank 7.5 ml/kg body weight (approximately 518 ml) of distilled water, 0.9% saline, or a 7% sucrose solution (positive control) on different days, with cold water (3 C) tested in a subgroup. Energy expenditure did not increase after drinking distilled water (P = 0.34) or 0.9% saline (P = 0.33), whereas 7% sucrose significantly increased it (P < 0.0001). Drinking water cooled to 3 C caused a small increase in energy expenditure of 4.5% over 60 min (P < 0.01), which was well below the theoretical energy cost of warming water to body temperature.
Brown CM, Dulloo AG, Montani JP J Clin Endocrinol Metab, 2006. PMID 16822824
2006 / Randomized clinical trial
Ninety-nine individuals with type 2 diabetes were randomly assigned to a low-fat vegan diet (n = 49) or an ADA guidelines diet (n = 50) for 22 weeks. Excluding participants who changed medications, HbA1c fell 1.23 points in the vegan group compared with 0.38 points in the ADA group (P = 0.01). Body weight decreased 6.5 kg in the vegan group compared with 3.1 kg in the ADA group (P < 0.001). Among those not changing lipid-lowering medications, LDL cholesterol fell 21.2% in the vegan group and 10.7% in the ADA group (P = 0.02), and urinary albumin reductions were also greater in the vegan group (15.9 mg/24 h vs. 10.9 mg/24 h, P = 0.013).
Barnard ND, Cohen J, Jenkins DJ, et al. Diabetes Care, 2006. PMID 16873779
2006 / Prospective analysis of randomized trial arm
Analyzing 1,079 adults across 3.2 years of an intensive lifestyle intervention, body weight reduction was the strongest predictor of lower diabetes incidence (hazard ratio 0.42 per 5-kg decrease, 95% CI 0.35-0.51; P < 0.0001). Each 1-kg reduction was linked to a 16% risk drop after adjusting for diet and activity. Among 495 participants missing initial weight loss goals, meeting exercise targets was associated with 44% lower incidence.
Hamman RF, Wing RR, Edelstein SL, et al. Diabetes Care, 2006. PMID 16936160
2006 / Intervention study
Overweight/obese postmenopausal women followed a low-fat (10-15% kcal), high-fiber (30-40 g per 1,000 kcal/day) diet and attended daily exercise classes for 2 weeks. Serum estradiol decreased in women on hormone treatment (n = 28) and those not on hormone treatment (n = 10), while serum insulin and IGF-I significantly decreased and IGF binding protein-1 increased across all women. Using subjects' serum in vitro, growth was reduced by 6.6% in MCF-7 cells, 9.9% in ZR-75-1 cells, and 18.5% in T-47D cells, while apoptosis increased by 20% in ZR-75-1, 23% in MCF-7, and 30% in T-47D cells (n = 12).
Barnard RJ, Gonzalez JH, Liva ME, et al. Nutr Cancer, 2006. PMID 16965238
2006 / Controlled animal experiment and human genetic association study
Mice were treated with resveratrol to evaluate its effects on mitochondrial function and metabolic homeostasis, alongside an analysis of SIRT1 genetics in humans. Resveratrol treatment significantly increased aerobic capacity in mice, evidenced by higher running time and oxygen consumption in muscle fibers, and protected against diet-induced obesity and insulin resistance. The effects were associated with induction of genes for oxidative phosphorylation and mitochondrial biogenesis via PGC-1alpha and SIRT1 activation. Additionally, three Sirt1 SNPs were associated with energy homeostasis in Finnish subjects.
Lagouge M, Argmann C, Gerhart-Hines Z, et al. Cell, 2006. PMID 17112576
2006 / Randomized controlled trial
A randomized trial of 48 adults aged 57 +/- 3 years evaluated 1-year changes in bone mineral density across caloric restriction, exercise, or a healthy lifestyle control. Caloric restriction decreased bone mineral density at the total hip (-2.2% +/- 3.1%), intertrochanter (-2.1% +/- 3.4%), and spine (-2.2% +/- 3.3%) compared to controls. Conversely, exercise-induced weight loss did not result in bone loss at any site despite comparable reductions in body weight.
Villareal DT, Fontana L, Weiss EP, et al. Arch Intern Med, 2006. PMID 17159017
2006 / Randomized controlled trial
A randomized prospective trial assigned 2,437 women with resected early-stage breast cancer to a dietary fat-reduction intervention (n = 975) or control (n = 1,462). After a median follow-up of 60 months, fat intake was lower in the intervention group (33.3 vs. 51.3 g/day at 12 months; P < .001), alongside a 6-pound lower mean body weight (P = .005). Relapse events occurred in 9.8% of the intervention group and 12.4% of controls, corresponding to a hazard ratio of 0.76 (95% CI = 0.60 to 0.98; P = .077 for stratified log rank, P = .034 for adjusted Cox model).
Chlebowski RT, Blackburn GL, Thomson CA, et al. J Natl Cancer Inst, 2006. PMID 17179478
2006 / Intervention trial with lean and obese comparisons
Researchers compared dominant gut bacteria between obese and lean individuals and evaluated changes during weight loss. The relative proportion of Bacteroidetes was decreased in obese people compared with lean people. This proportion increased with weight loss achieved through two types of low-calorie diets.
Ley RE, Turnbaugh PJ, Klein S, et al. Nature, 2006. PMID 17183309
2005 / Randomized controlled trial
Eighty obese patients with knee osteoarthritis were randomized to an intensive low-energy diet (3.4 MJ/day) with weekly counseling or a control diet (5 MJ/day) with written guidance. The low-energy group lost 11.1% of body weight compared to 4.3% in controls (difference 6.8%, 95% CI: 5.5 to 8.1%, P < 0.0001). Total WOMAC scores improved in the low-energy cohort (mean difference -219.3 mm, P = 0.005), and every 1% reduction in body fat predicted a 9.4% improvement in symptoms.
Christensen R, Astrup A, Bliddal H Osteoarthritis Cartilage, 2005. PMID 15639633
2005 / Randomized crossover trial
A randomized crossover study in 10 healthy obese women tested 14 days of a regular meal frequency (6 meals daily) versus an irregular pattern (3 to 9 meals daily). Regular eating resulted in lower reported energy intake (P < 0.01), enhanced postprandial thermogenesis (P < 0.01), and lower fasting total and LDL cholesterol (P < 0.01 and P < 0.02, respectively). Peak postprandial insulin and insulin area under the curve were also significantly reduced.
Farshchi HR, Taylor MA, Macdonald IA Am J Clin Nutr, 2005. PMID 15640455
2005 / Randomized controlled trial
In a 6-week randomized trial, 61 overweight and obese participants followed energy-restricted diets with either 200 g/d of avocado substituting for 30 g of other dietary fats or an avocado-free control. Fifty-five individuals completed the trial. Measures of body weight, BMI, and percent body fat dropped significantly in both arms (P < 0.001), with similar changes between groups. Blood lipids, fibrinogen, arterial compliance, and blood pressure showed no significant shifts within or between groups.
Pieterse Z, Jerling JC, Oosthuizen W, et al. Nutrition, 2005. PMID 15661480
2005 / Interventional crossover trial
Ten obese women completed two 2-week isocaloric diet periods containing either 16% (low-fat) or 56% (high-fat) of energy as fat. Baseline liver fat averaged 10 +/- 7%; it decreased by 20 +/- 9% during the low-fat diet and increased by 35 +/- 21% during the high-fat diet (P = 0.042 for change between diets). Fasting serum insulin decreased from 70 +/- 41 pmol/liter at baseline to 60 +/- 24 pmol/liter after the low-fat diet and increased to 81 +/- 44 pmol/liter after the high-fat diet (P = 0.005 for change between diets). Serum lipids, free fatty acids, and intraabdominal and subcutaneous fat masses remained unchanged.
Westerbacka J, Lammi K, Häkkinen AM, et al. J Clin Endocrinol Metab, 2005. PMID 15741262
2005 / Randomized controlled trial
A randomized trial evaluated a 40-hour lifestyle education program over 4 weeks among 337 community volunteers aged 43 to 81 years. At 6 weeks, the intervention group demonstrated significant beneficial improvements in health knowledge, physical activity, percent body fat, resting heart rate, total cholesterol, LDL cholesterol, and blood pressure. For nearly all assessed variables, improvements were significantly greater in the intervention group than in the control group.
Aldana SG, Greenlaw RL, Diehl HA, et al. J Am Diet Assoc, 2005. PMID 15746824
2005 / Randomized controlled trial
A randomized controlled trial in 1,471 postmenopausal women tested 1 gram daily of calcium against placebo over 30 months. Weight loss did not differ between the calcium group (368 +/- 132 g) and placebo group (369 +/- 134 g, P = 0.93), with no effects on fat or lean mass. Systolic blood pressure showed a transient 1 to 2 mm Hg reduction at 6 months (P = 0.048), but between-group differences were not significant at 30 months.
Reid IR, Horne A, Mason B, et al. J Clin Endocrinol Metab, 2005. PMID 15827103